← Back to Search

Exercise and diet for Kidney Transplant (IMPACT Trial)

N/A
Waitlist Available
Led By Larissa Myaskovsky, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 year
Awards & highlights

IMPACT Trial Summary

This trial will test a lifestyle intervention for kidney transplant recipients that includes diet and exercise, to see if it is feasible and acceptable.

IMPACT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Acceptability: Satisfaction
Intervention Acceptability: Usability
Intervention feasibility: Attrition
+3 more
Secondary outcome measures
Medical records outcomes: HbA1c
Medical records outcomes: Lipids
Medical records outcomes: Weight
+3 more

IMPACT Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
No exercise or diet specialization.
Group II: IMPACT InterventionExperimental Treatment1 Intervention
Incorporate a rehabilitation approach to slowly increasing KT recipients' physical activity in addition to individualized dietary intervention at every post-transplant appointment through six months post-transplant, with follow-up at 12 months post-transplant.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise and diet
2020
Completed Phase 4
~6200

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
372 Previous Clinical Trials
3,528,766 Total Patients Enrolled
Larissa Myaskovsky, PhDPrincipal InvestigatorUniversity of New Mexico
2 Previous Clinical Trials
895 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing recruitment for participants in this experiment?

"This treatment trial, which was initially posted on November 1st 2020 and last updated February first 2022, is no longer actively searching for participants. However, two other studies are currently recruiting patients."

Answered by AI

What are the ultimate objectives of this experiment in healthcare?

"This medical trial seeks to measure Intervention Acceptability and Usability over a one-year period. Secondary goals include the assessment of HbA1c through Medical Records, Quality of Life as determined by PROMIS Scale v1.2 Global Health Measure, and Occupational Functioning evaluated via CHART-SF which assigns scores between 0 - 100 where higher numbers denote greater levels of participation."

Answered by AI
~5 spots leftby Apr 2025